Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelActive Internal RP 4.3x18mm: medical device reports filed with FDA

1,514 reports name it, 2019–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

1,514
device reports naming the brand
0% of all MAUDE reports · about 222 a year
224
reports, 12 months to August 2026
164 in the 12 months before
1.5%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,514 medical device reports received by FDA name the brand "NobelActive Internal RP 4.3x18mm" (endosseous dental implant); the manufacturer given most often on reports is Nobel Biocare; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

224 reports arrived in the 12 months to August 2026, up 37% from 164 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.5%) and malfunction (1.5%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (57.7%), loss of osseointegration (29.5%) and osseointegration problem (5.3%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02040Sep 2021: 25Oct 2021: 15Nov 2021: 18Dec 2021: 242022Jan 2022: 21Feb 2022: 9Mar 2022: 11Apr 2022: 15May 2022: 11Jun 2022: 9Jul 2022: 21Aug 2022: 25Sep 2022: 10Oct 2022: 17Nov 2022: 21Dec 2022: 142023Jan 2023: 21Feb 2023: 11Mar 2023: 34Apr 2023: 24May 2023: 22Jun 2023: 13Jul 2023: 23Aug 2023: 18Sep 2023: 23Oct 2023: 23Nov 2023: 14Dec 2023: 112024Jan 2024: 21Feb 2024: 5Mar 2024: 18Apr 2024: 22May 2024: 30Jun 2024: 22Jul 2024: 17Aug 2024: 8Sep 2024: 10Oct 2024: 14Nov 2024: 12Dec 2024: 102025Jan 2025: 20Feb 2025: 14Mar 2025: 16Apr 2025: 6May 2025: 0Jun 2025: 0Jul 2025: 40Aug 2025: 22Sep 2025: 12Oct 2025: 10Nov 2025: 8Dec 2025: 282026Jan 2026: 30Feb 2026: 16Mar 2026: 10Apr 2026: 22May 2026: 20Jun 2026: 24Jul 2026: 24Aug 2026: 20

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01252502019: 10720192020: 20520202021: 25020212022: 18420222023: 23720232024: 18920242025: 17620252026: 1662026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.5%1,492
Malfunction1.5%22
Other0%0
Not given0%0

Who filed the report

Manufacturer report59.6%902
Voluntary report0%0
User facility report0%0
Distributor report40.4%612
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate87357.7%62.8%
Loss of osseointegration44629.5%22.4%
Osseointegration problem805.3%7.7%
Fracturea broken bone714.7%1.6%
Patient device interaction problem60.4%0.3%
Insufficient device problem information50.3%0.2%
Premature separation40.3%0.1%
Malposition of device20.1%0.1%
Migrationthe device moved from where it was placed20.1%0.1%
Device damaged by another device10.1%0%
Device markings/labelling problema problem with the device markings or label10.1%0%
Material deformation10.1%0.1%
Separation failure10.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,21480.2%
Painpain, site not specified19612.9%
Numbnessnumbness241.6%
Appropriate clinical signs, symptoms and conditions term/code not available120.8%
Implant pain80.5%
Sinus perforation30.2%
Abscessa collection of pus20.1%
Fistula20.1%
Foreign body in patientpart of a device left in the patient20.1%
Inflammationinflammation20.1%
Osteomyelitis20.1%
Bone fracture(s)10.1%
Hypersensitivity/allergic reaction10.1%
Swelling/ edema10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelActive Internal RP 4.3x18mmProduct code DZEAll MAUDE reports
Reports1,5143,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury98.5%99.2%36.2%
Classified as malfunction1.5%0.8%62.3%
Filed by the manufacturer59.6%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelActive Internal RP 4.3x18mm reports

How many FDA reports name NobelActive Internal RP 4.3x18mm?

1,514 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 224 in the latest 12 months.

What kinds of events are reported?

injury (98.5%) and malfunction (1.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (57.7%), loss of osseointegration (29.5%), osseointegration problem (5.3%), fracture (4.7%) and patient device interaction problem (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (59.6%) and distributor reports (40.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelActive Internal RP 4.3x18mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.